Anti-HGFR / c-Met Reference Antibody (telisotuzumab vedotin), IgG1

Produktübersicht

• Artikelname: Anti-HGFR / c-Met Reference Antibody (telisotuzumab vedotin), IgG1
• Artikelnummer: SYB-CHB249
• Hersteller Artikelnummer: CHB249
• Alternativnummer: SYB-CHB249-100UG,SYB-CHB249-1MG
• Hersteller: Sanyou Bio
• Kategorie: Antikörper
• Applikation: ELISA, FA, FACS, Kinetics
• Spezies Reaktivität: Human
• Alternative Synonym: ABBV-399

Produktbeschreibung

Telisotuzumab vedotin is an ADC consisting of a cMET-directed antibody and Monomethyl auristatin E (MMAE) that has recently obtained the breakthrough therapy designation (BTD) for the treatment of patients with c-Met overexpression, advanced/metastatic wild-type (WT) epithelial growth factor receptor (EGFR) non-squamous non-small cell lung cancer (sqNSCLC) that progressed during or after platinum-based chemotherapy.

Produkteigenschaften

• Konzentration: 1mg/ml
• Molekulargewicht: 151.37 kDa
• Isotyp: IgG1
• NCBI: 08581
• UniProt: P08581
• Puffer: 25mM histidine, 8% sucrose, 0.01% Tween80 pH6.2
• Reinheit: >90%
• Formulierung: Lyophilize
• Target-Kategorie: HGFR / c-Met